Bill Ackman Sells Valeant Stake After $2.8 Billion Loss

Bill Ackman has sold his entire stake in Valeant Pharmaceuticals International Inc. and will leave the board after his Pershing Square Capital Management lost at least $2.8 billion. Bloomberg Intelligence's Liz Krutoholow reports on "Bloomberg Daybreak: Americas." (Source: Bloomberg)

Singer on Intimidating CEOs and Knocking on Open Doors
26:12 - Elliott Management Founder and Co-CEO Paul Singer discusses his reputation for striking fear in the hearts of CEOs and reveals that sometimes he's "knocking on an open door" when he approaches management with suggestions for change. He speaks to David Rubenstein on "The David Rubenstein Show: Peer-to-Peer Conversations." (Source: Bloomberg)
  • Full Show: Bloomberg Markets Middle East (07/26)
  • DeMint: Trump Should 'Absolutely Not' Fire AG Sessions
  • Ford CFO Credits Tax Team's 'Fantastic Job' in 2Q